Inhibitors of protein tyrosine kinase activity
US8404846B2 · kind B2 · utility
8Cited by
1References
49Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2008 |
| Grant date | Mar 26, 2013 |
| Priority date | — |
| Expiry date | Sep 22, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling and HGF receptor signaling. More particularly, the invention relates to compounds, compositions and methods for the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.